Eriko Morino, Sohtaro Mine, Noriko Tomita, Yukari Uemura, Yosuke Shimizu, Sho Saito, Tetsuya Suzuki, Nobumasa Okumura, Haruka Iwasaki, Junko Terada, Akira Ainai, Yusuke Sakai, Eunsil Park, Sayuri Seki, Daisuke Akazawa, Masayuki Shimojima, Nozomi Shiwa-Sudo, Milagros Virhuez-Mendoza, Kosuke Miyauchi, Saya Moriyama, Naoko Iwata-Yoshikawa, Michiko Harada, Shigeyoshi Harada, Takayuki Hishiki, Ryutaro Kotaki, Takayuki Matsumura, Sho Miyamoto, Takayuki Kanno, Masanori Isogawa, Koichi Watashi, Noriyo Nagata, Hideki Ebihara, Yoshimasa Takahashi, Ken Maeda, Tetsuro Matano, Takaji Wakita, Tadaki Suzuki, Wataru Sugiura, Norio Ohmagari, Mugen Ujiie
Mpox Neutralizing Antibody Response to LC16m8 VaccineIn this study of 50 healthy volunteers in Japan, a smallpox vaccine (LC16m8) exhibited a robust neutralizing antibody response against two strains of the mpox virus. With a 94% "take" rate by day 14, seroconversion rates on day 28 were 72 and 70% against the Zr599 and Liberia strains, respectively, decreasing to 30% for both on day 168; no serious adverse events occurred.
March 2024: NEJM Evid